ClearNote Health
Develops epigenomic liquid biopsy tests for early cancer detection.
Company facts
- Founded
- 2016
- Employees
- 50
- Headquarters
- United States
- Type
- Private
- Funding
- Series C · $21.8M · 2025
Develops epigenomic liquid biopsy tests for early cancer detection.
Company facts